HEARTBEAM, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
HEARTBEAM, INC. (BEAT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$21.02 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- HEARTBEAM, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$21.02B.
- HEARTBEAM, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$19.45B.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$21.02B 10-K · filed 2026-03-12 |
| 2024-12-31 | -$19.45B 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |